Show simple item record

 
dc.contributorDepartament de Salut
dc.contributor.authorFolch, Cinta
dc.contributor.authorCasabona, Jordi
dc.contributor.authorMajó-Roca, Xavier
dc.contributor.authorMeroño, Mercè
dc.contributor.authorGonzález, Victoria
dc.contributor.authorColom-Farran, Joan
dc.contributor.authorBrugal, Teresa
dc.contributor.authorEspelt, Albert
dc.date.accessioned2022-02-03T12:42:56Z
dc.date.available2022-02-03T12:42:56Z
dc.date.issued2021-11-05
dc.identifier.citationFolch C, Casabona J, Majó X, Meroño M, González V, Colom J, et al. Mujeres que usan drogas inyectadas y violencia: necesidad de una respuesta integrada. Adicciones. 2021 Nov 5;33(4):299-306.
dc.identifier.issn0214-4840
dc.identifier.urihttp://hdl.handle.net/11351/6964
dc.descriptionHepatitis C; Women; Drugs; Violence
dc.description.abstractThe aim of this study was to describe the prevalence of physical and/ or sexual violence experienced by women who inject drugs (WWID) and identify associated factors. A cross-sectional study was conducted among 120 WWID in a network of harm reduction centres using an anonymous questionnaire. Oral fluid samples were also collected to estimate the prevalence of HIV and hepatitis C. Univariate and multivariate Poisson regression models with robust variance were performed to identify the factors associated with experiencing violence, obtaining prevalence ratios (PR) and their 95% confidence intervals. The results showed that the prevalence of violence reported by WWID in the last 12 months was 45.8% (42.2% physical and 11.9% sexual aggression). In multivariate analysis, variables associated with experiencing violence were homelessness (PR = 1.59; CI: 1.07-2.38), reporting exchanges of sex for money or drugs (PR = 1.65; CI: 1.19- 2.29), reporting a previous sexually transmitted infection (PR = 1.49; CI: 1.04-2.15) and/or injecting drugs less frequently than daily (RP = 2.29; CI: 1.49-3.54). This study highlights the importance of establishing detection protocols and systems of referral to the network of attention to women suffering violence, within the centres of the drug addiction care network, as well as the development of multilevel strategies that take into account not only individual factors but also other social and/or structural aspects that may be playing a relevant role in addressing this problem.
dc.language.isospa
dc.language.isoeng
dc.publisherSocidrogalcohol
dc.relation.ispartofseriesAdicciones;33(4)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectViolència envers les dones
dc.subjectDones - Consum de drogues
dc.subjectHepatitis C
dc.subject.meshHepatitis C
dc.subject.meshDrug Users
dc.subject.meshViolence Against Women
dc.titleMujeres que usan drogas inyectadas y violencia: necesidad de una respuesta integrada
dc.title.alternativeWomen who inject drugs and violence: need for an integrated response
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.20882/adicciones.1322
dc.subject.decshepatitis C
dc.subject.decsconsumidores de drogas
dc.subject.decsviolencia contra la mujer
dc.relation.publishversionhttps://doi.org/10.20882/adicciones.1322
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliation[Folch C, Casabona J] Centre d’Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. [Majó X, Colom J] Sub-direcció General de Drogodependències. Programa de Prevenció, Control i Atenció al VIH, les ITS i les Hepatitis Víriques (PCAVIHV), Agència de Salut Pública de Catalunya, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. [Meroño M] Fundació Àmbit Prevenció, Barcelona, Spain. [González V] Centre d’Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. Servicio de Microbiología. Laboratori Clínic de la Metropolitana Nord. Hospital Universitari Germans Trias i Pujol, Badalona, Spain. [Brugal MT] Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Agència de Salut Pública de Barcelona, Barcelona, Spain. [Espelt A] Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Agència de Salut Pública de Barcelona, Barcelona, Spain. Facultat de Ciències de la Salut de Manresa. Universitat de Vic Universitat Central de Catalunya (UVicUCC), Manresa, Spain
dc.identifier.pmid32677694
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record